Skip to main content

Market Overview

Morgan Stanley, Chubb, CVS Health And An ETF Up 19% YTD: CNBC's 'Final Trades'

Share:
Morgan Stanley, Chubb, CVS Health And An ETF Up 19% YTD: CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management said JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ: JEPQ) has a distribution yield of around 10%

Josh Brown of Ritholtz Wealth Management named Chubb Limited (NYSE: CB), which is an insurance name.

Chubb reported better-than-expected second-quarter results.

Benzinga's analyst rating's data shows a consensus Overweight rating on Chubb.

Sarat Sethi said Morgan Stanley (NYSE: MS) was unfairly beaten down on Tuesday and has nothing to do with regional banks.

Morgan Stanley recently reported better-than-expected second-quarter financial results.

Stephanie Link of Hightower said CVS Health Corporation (NYSE: CVS) is "really cheap."

CVS Health’s second-quarter sales increased 10.3% year-over-year to $88.9 billion, beating the consensus of $86.74 billion, driven by growth across all segments. Adjusted EPS was $2.21, beating the consensus of $2.12.

Don’t forget to check out our premarket coverage here

Price Action: CVS Health shares gained 0.1% to settle at $74.00, while Morgan Stanley shares fell 0.7% to close at $88.47 on Tuesday. Chubb shares declined 1% to $201.08, while JPMorgan Nasdaq Equity Premium Income ETF fell 0.7% to $48.41 on Tuesday.

Check This Out: Investor Sentiment Declines After Moody's Downgrades Credit Ratings Of Banks

Photo: Shutterstock

 

Related Articles (CB + CVS)

View Comments and Join the Discussion!

Posted-In: Bryn Talkington CNBC Halftime Report Final TradesLong Ideas News Markets Media Trading Ideas Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com